Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes
Clinical trial NCT05949281 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05949281
- Sponsor
- Asger Lund, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-29
- Primary completion
- 2031-01-15
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.